|
|
|
Volumn 5, Issue 1, 2004, Pages 29-33
|
|
Editorial overview: A return to the fundamentals of drug discovery?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE;
APREPITANT;
ARIPIPRAZOLE;
CIMETIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
NEUROKININ 1 RECEPTOR ANTAGONIST;
NEUROLEPTIC AGENT;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
DRUG;
BIOTECHNOLOGY;
CARCINOGENICITY;
CLINICAL PHARMACOLOGY;
COMBINATORIAL CHEMISTRY;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SYNTHESIS;
DRUG TARGETING;
EDITORIAL;
FINANCIAL MANAGEMENT;
GENE TECHNOLOGY;
GENOMICS;
HEALTH CARE SYSTEM;
HUMAN;
HUMAN GENOME;
LABORATORY TEST;
LICENSING;
MEDICAL ETHICS;
MEDICAL RESEARCH;
MOLECULAR BIOLOGY;
NONHUMAN;
PATENT;
PROTEOMICS;
PUBLIC HEALTH SERVICE;
SIDE EFFECT;
ANIMAL;
DRUG DESIGN;
METHODOLOGY;
PHARMACOLOGY;
RAT;
RESEARCH;
SYNTHESIS;
ANIMALS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
PHARMACOLOGY;
RATS;
RESEARCH;
|
|
EID: 2342444862
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (29)
|
|
References (0)
|
